94105 ⎘
Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring; Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring; Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom 1-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof
PROCESS FOR THE PREPARATION OF INDOMETHACIN
#2NOVEL SELENO-NSAID ANALOGS AND USES THEREOF
#3Augmenting moieties for anti-inflammatory compounds
#4Curcumin conjugates and methods of use thereof
#5Unique dual-action therapeutics
#6Liver targeted conjugates
#7PHTHALIMIDE DERIVATIVES OF NON-STEROIDAL ANTI-INFLAMMATORY COMPOUNDS AND/OR TNF-ALPHA MODULATORS, METHOD FOR PRODUCING SAME, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND USES THEREOF FOR THE TREATMENT OF INFLAMMATORY DISEASES
#8Unique Dual-Action Therapeutics
#9Nitric Oxide Releasing Prodrugs of Therapeutic Agents
#10ARYL ALKYL CARBOXYLIC ACID SALTS, PROCESS FOR PREPARATION AND DOSAGE FORMS
#11SALT OF NONSTEROIDAL ANTI-INFLAMMATORY DRUG AND ORGANIC AMINE COMPOUND AND USE THEREOF
#12COX-2-TARGETED IMAGING AGENTS
#13LIVER TARGETED CONJUGATES
#14COPPER COMPLEXES
#15COMPOSITIONS AND METHODS TO PREVENT TOXICITY INDUCED BY NONSTEROIDAL ANTIINFLAMMATORY DRUGS
#16Novel Nsaids Possessing a Nitric Oxide Donor Diazen-1-Ium-1,2-Diolate Moiety
#17Aralkyl ester soft drugs
#18Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
#19Method and compositions for temporarily incapacitating subjects
#20Ophthalmic compositions for treating ocular hypertension
#21Geminally di-substituted NSAID derivatives as Aβ42 lowering agents
#22Synthesis of COX-2 and FAAH inhibitors
#23Modulators of CRTH2, COX-2 and FAAH
#24Pharmaceutically active salts and esters of 1-dimethylamino-3-(3-methoxyphenyl)-2-methylpentan-3-ol and 3- (3-dimethylamino-1-ethyl-1-hydroxy-2-methylpropyl)-phenol and methods of using same
#25Use of nitroderivatives in urinary incontinence
#26Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
#27COX-2 and FAAH inhibitors
#28Prodrugs of non-steroidal anti-inflammatory and carboxylic acid containing compounds
#29COX-2-targeted imaging agents